Vasomedical Looks To CMS Coverage, Trial Publication To Boost Revenue
This article was originally published in The Gray Sheet
Executive Summary
Vasomedical is counting on CMS to issue a national coverage decision for the Lumenair EECP enhanced external counterpulsation therapy for angina and heart failure patients to help boost dwindling revenue